MedPath

MENJUGATE

MENJUGATE

Discontinued
DIN Number

02243820

Drug Class

Human

Market Date

Sep 5, 2001

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02243820
AIG Number0243741001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AH MENINGOCOCCAL VACCINES
Product Specifications
Dosage FormPowder For Suspension
Route of AdministrationIntramuscular
AHFS Classification80:08.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEINActive
Strength: 25 MCG / 0.5 ML
Monograph: CORYNEBACTERIUM DIPHTHERIAE CRM-197 PROTEIN
MENINGOCOCCAL GROUP C OLIGOSACCHARIDEActive
Strength: 10 MCG / 0.5 ML
Monograph: MENINGOCOCCAL GROUP C OLIGOSACCHARIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.